Caroline Schneider, PA
Orthopaedic Surgery of the Spine · New Orleans, LANPI 1669092326
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 13 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Nevro Corp. at 30.5% of the total. That places this record below the midpoint for orthopaedic surgery of the spine clinicians in LA, where the typical reported total is $12,239.
Across 13 payments — averaging $49.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$195
- SPR Therapeutics, Inc$146
- Relievant Medsystems, Inc.$132
- Ferring Pharmaceuticals Inc.$57
- Ipsen Biopharmaceuticals, Inc$48
- Bioventus LLC$23
- plus $39 from 2 others
What the payments were for
- Food & beverage$641100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 2 | $195 |
| SPR Therapeutics, Inc | 2 | $146 |
| Relievant Medsystems, Inc. | 1 | $132 |
| Ferring Pharmaceuticals Inc. | 3 | $57 |
| Ipsen Biopharmaceuticals, Inc | 2 | $48 |
| Bioventus LLC | 1 | $23 |
| Medtronic | 1 | $22 |
| Vertex | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$528
- Senza$149
- SPRINT PNS System$124
How this compares
$641 in reported general payments places this provider in the 10th percentile of 29 orthopaedic surgery of the spine providers in Louisiana.
See all orthopaedic surgery of the spine providers in Louisiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 795 | $7,172 |
| Pregabalin | 257 | $2,784 |
| Methocarbamol | 320 | $2,718 |
| Celecoxib | 131 | $1,166 |
| Methylprednisolone | 164 | $1,154 |
| Lidocaine | 16 | $1,115 |
| Tizanidine Hcl | 97 | $931 |
| Cyclobenzaprine Hcl | 91 | $929 |
| Oxycodone Hcl | 169 | $698 |
| Baclofen | 38 | $549 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 62 | $519 |
| Meloxicam | 96 | $353 |
| Diclofenac Sodium | 21 | $284 |
| Ibuprofen | 13 | $190 |
| Tramadol Hcl | 28 | $85 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery of the spine in New Orleans
- Mathew CyriacNew Orleans$368K
- Charles YuNew Orleans$52K
- William AccoustiNew Orleans$46K
- Amit BhandutiaNew Orleans$39K
- Felipe Ramirez-TerrassaNew Orleans$15K
- Andrew ToddNew Orleans$12K
- Parth DesaiNew Orleans$6K
- Andrew KingNew Orleans$5K
- Paul DimartinoNew Orleans$165
- Joseph ZavatskyMetairie$205K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.